ACTG Publications

Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression.Hoenigl, Martin ; Moser, Carlee ; Funderburg, Nicholas ; Bosch, Ronald ; Kantor, Amy ; Zhang, Yonglong ; Eugen-Olsen, Jesper ; Finkelman, Malcolm ; Reiser, Jochen ; Landay, Alan ; Moisi, Daniela ; Lederman, Michael M ; Gianella, Sara ; ACTG NWCS 411 study team2018 Nov 12Clin Infect Dis
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.Tassiopoulos, Katherine ; Landay, Alan ; Collier, Ann C ; Connick, Elizabeth ; Deeks, Steven G ; Hunt, Peter ; Lewis, Dorothy E ; Wilson, Cara ; Bosch, Ronald2012 JunJ Infect Dis11205
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174.Smith, Kimberly ; Zheng, Lu ; Bosch, Ronald ; Margolis, David M ; Tenorio, Allan ; Napolitano, Laura ; Saag, Michael ; Connick, Elizabeth ; Gross, Barry ; Francis, Isaac ; Valdez, Hernan ; Muurahainen, Norma ; Stocker, Vicky ; Pollard, Richard2010 AprAIDS Res Hum Retroviruses426
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.Weinberg, Adriana ; Park, Jeong-Gun ; Bosch, Ronald ; Cho, Alice ; Livingston, Elizabeth ; Aweeka, Fran ; Cramer, Yoninah ; Watts, D Heather ; Luque, Amneris E ; Cohn, Susan E2016 Feb 1J Acquir Immune Defic Syndr271
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.Weinberg, Adriana ; Bosch, Ronald ; Bennett, Kara ; Tovar-Salazar, Adriana ; Benson, Constance A ; Collier, Ann C ; Zolopa, Andrew ; Gulick, Roy M ; Wohl, David ; Polsky, Bruce ; Erice, Alejo ; Jacobson, Mark A2014 May 1J Acquir Immune Defic Syndr166